California 2023-2024 Regular Session

California Assembly Bill AB19

Introduced
12/5/22  
Refer
1/26/23  
Introduced
12/5/22  
Introduced
12/5/22  
Report Pass
2/27/23  
Refer
1/26/23  
Refer
1/26/23  
Report Pass
2/27/23  
Report Pass
2/27/23  
Refer
2/28/23  
Report Pass
4/13/23  
Refer
2/28/23  
Refer
2/28/23  
Report Pass
4/13/23  
Refer
4/13/23  
Refer
4/26/23  
Refer
4/13/23  
Refer
4/26/23  
Report Pass
5/18/23  
Report Pass
5/18/23  
Report Pass
5/18/23  
Engrossed
5/25/23  
Engrossed
5/25/23  
Engrossed
5/25/23  
Refer
5/26/23  
Refer
5/26/23  
Refer
5/26/23  
Refer
6/7/23  
Report Pass
6/21/23  
Refer
6/7/23  
Refer
6/7/23  
Refer
6/22/23  
Report Pass
6/21/23  
Report Pass
6/21/23  
Refer
7/10/23  
Refer
6/22/23  
Refer
6/22/23  
Refer
7/10/23  

Caption

Pupil health: opioid antagonists.

Impact

The bill imposes additional duties on public schools and creates a state-mandated local program. Under California law, if these mandates lead to additional costs for schools, the state must reimburse them accordingly. This aspect of the bill is crucial as it not only places responsibilities on educational institutions to stock and manage naloxone supplies but also aligns with existing state mandates that ensure local agencies are financially supported for state-imposed costs.

Summary

Assembly Bill 19, introduced by Joe Patterson and co-authored by various assembly and senate members, aims to enhance pupil health by mandating the availability of opioid antagonists, specifically naloxone hydrochloride, in public schools. The bill requires each school that has a nurse or trained personnel to maintain at least two doses of naloxone for use in emergency situations involving opioid overdoses. The provision aims to ensure that medical help is readily accessible in schools, where timely intervention can significantly save lives in overdose situations.

Sentiment

Discussions around AB 19 are generally supportive, with proponents viewing it as a necessary step in addressing the growing opioid crisis, particularly within school environments where young people are affected. Advocates argue that having naloxone on hand could make a critical difference in emergency situations. However, there are concerns regarding the implementation logistics, like the training of staff and potential funding implications for resources needed to maintain and manage these programs, which may lead to mixed sentiments among stakeholders.

Contention

Despite the broad support, some opposition exists regarding the additional burden placed on schools and the potential challenges in training staff effectively to use naloxone. Critics argue about the adequacy of training and the implications of relying on school personnel to respond to such emergencies. The discussion also touches on broader issues relating to the opioid epidemic and the resource constraints that schools face, raising questions about prioritization and funding for health and safety initiatives.

Companion Bills

No companion bills found.

Similar Bills

CA AB3271

Pupil health: opioid antagonists.

CA SB472

Pupil health: opioid overdose reversal medication.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.

CA AB915

Pupil health: drug education: opioid overdose training program.

CA AB1915

Pupil health: drug education: opioid overdose training program.

CA AB2998

Opioid overdose reversal medications: pupil administration.

CA AB1037

Public health: substance use disorder.